Study of Normal Conditions of Use, Dosing, and Safety of Intravenous (IV) Administration of Vernakalant (MK-6621-049)
Clinical trial NCT01370629 · COMPLETED
Trial details
- NCT number
- NCT01370629
- Sponsor
- Correvio International Sarl
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-08-01
- Primary completion
- 2018-04-05
- Enrollment
- 2015
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.